INOVIO PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Inovio Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2024.
  • Inovio Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 26.1M shares, a 90.3% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 26.1M -244M -90.3% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 26M -242M -90.3% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 23.4M -239M -91.1% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 22.8M +1.7M +8.07% Dec 31, 2023 10-K 2024-03-06
Q3 2023 270M +20.2M +8.12% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 268M +20.6M +8.31% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 263M +36.2M +16% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 21.1M -196M -90.3% Dec 31, 2022 10-K 2024-03-06
Q3 2022 249M +39.1M +18.6% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 248M +37.4M +17.8% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 227M +17.2M +8.21% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 217M +30.5M +16.3% Dec 31, 2021 10-K 2023-03-01
Q3 2021 210M +42.8M +25.6% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 210M +51.4M +32.4% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 209M +63.4M +43.5% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 187M +85.5M +84.3% Dec 31, 2020 10-K 2022-03-01
Q3 2020 168M +68.5M +69.1% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 159M +60.2M +61% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 146M +48M +49% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 101M +4.14M +4.25% Dec 31, 2019 10-K 2021-03-01
Q3 2019 99M +4.57M +4.84% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 98.6M +7.11M +7.77% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 97.9M +7.23M +7.97% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 97.2M +6.87M +7.6% Dec 31, 2018 10-K 2020-03-12
Q3 2018 94.5M +4.18M +4.63% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 91.5M +13.8M +17.8% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 90.7M +16.1M +21.5% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 90.4M +16.3M +22% Dec 31, 2017 10-K 2019-03-12
Q3 2017 90.3M +16.3M +22.1% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 77.6M +4.15M +5.65% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 74.6M +2.36M +3.26% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 74.1M +1.84M +2.55% Dec 31, 2016 10-K 2018-03-14
Q3 2016 74M +1.79M +2.47% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 73.5M +1.67M +2.33% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 72.3M +11.5M +19% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 72.2M +11.5M +18.9% Dec 31, 2015 10-K 2017-03-15
Q3 2015 72.2M +11.7M +19.4% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 71.8M +11.5M +19.1% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 60.7M -179M -74.7% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 60.7M +8.16M +15.5% Dec 31, 2014 10-K 2016-03-14
Q3 2014 60.5M -147M -70.9% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 60.3M -120M -66.5% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 240M +60.2M +33.5% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 52.6M -91.7M -63.6% Dec 31, 2013 10-K 2015-03-16
Q3 2013 208M +27.7M +15.4% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 180M +118K +0.07% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 180M Mar 31, 2013 10-Q 2013-05-10
Q4 2012 144M +9.34M +6.92% Dec 31, 2012 10-K 2014-03-17
Q3 2012 180M Sep 30, 2012 10-Q 2013-11-12
Q2 2012 180M Jun 30, 2012 10-Q 2013-08-09
Q4 2011 135M +29.9M +28.5% Dec 31, 2011 10-K 2013-03-18
Q4 2010 105M Dec 31, 2010 10-K 2012-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.